Bioburden Testing Market: Global Industry Analysis and Forecast (2022-2027)

Bioburden Testing Market size is expected to grow at a CAGR of 13.4% during the forecast period and the market size is expected to reach nearly USD 2.27 billion by 2027. Bioburden testing is a technique of measuring possible microorganisms on medical devices and helps in defining the parameters required for sterilisation process to ensure safety and effectiveness of medical devices. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Global Bioburden Testing Market To know about the Research Methodology :- Request Free Sample Report The scope of the report includes a detailed study of global and regional markets for bioburden testing with the reasons given for variants in the growth of the industry in certain regions. The market growth can be attributed to the factors like growth in food, medical devices, pharmaceutical and biotechnology industries, increasing product recalls due to microbial contamination, and increasing healthcare business and medical spending. Many regulations have been made to check all the parameter of safety and cleaning in the industry or their products. For instance, in the USA Title 21 is the code of federal regulation that covers the drugs and food for the FDA. Various other organizations are also having the code and standard parameter for monitoring. However, lack of skilled professionals, expensive cost of instruments and lengthy approval procedures are hindering the market growth. The factors such as a growing preference for contract manufacturing and emerging economies are creating profitable opportunities for market growth. The report on global bioburden testing market covers segments such as product, test, application and region. Based on product, consumables accounted for the largest XX% market share in the global bioburden testing market, because of the high requirement of kits and reagents, whereas the instruments are a one-time investment. The long shelf life of the kits and reagents and the repetitive purchase of media, kits, and reagents are driving the adoption of the bioburden testing consumables. The aerobic segment generated the largest market xx% share in 2021 because of its wide application for determining the total bacterial population on a sample. Moreover, it is used for sanitary inspection and organoleptic check especially food products. Anaerobic count tests, on the other hand, are also needed, as anaerobic bacteria are common causes of infection. North America was the largest regional bioburden testing market in terms of revenue. Sustained growth in pharmaceutical and biotechnology industries, the increasing food and medicine safety concerns in general public, and a strong trend of R&D investments in life sciences, by both industry and academia, are the main factors driving the growth of the market. Growing government support for pharmaceutical and biotechnology companies is also impacting the growth of the market in North America. Major leading players operating in the market for bioburden testing like Charles River Laboratories is the prominent player in the bioburden testing market. The leading position of the Charles River Company is attributed to its robust product portfolio which comprises traditional as well as innovative technology platforms that help streamline bioburden testing. The company’s extensive presence across the globe has also played an important role in securing its position in the bioburden testing market. The report covers recent developments in the global bioburden testing market such as in 2018, Charles River acquired MPI Research, a leading nonclinical contract research organization (CRO). This acquisition boosted Charles River’s ability to partner with clients across the drug discovery and development continuum. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Bioburden Testing Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment shortly to the emerging segment in the Global Bioburden Testing Market.

Bioburden Testing Market Scope: Inquire before buying

Global Bioburden Testing Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.07 Bn.
Forecast Period 2022 to 2027 CAGR: 13.4% Market Size in 2027: US $ 2.27 Bn.
Segments Covered: by Product • Instruments o PCR o Microscopes • Consumables • Kits • Reagents
by Test • Aerobic • Anaerobic • Fungi • Spore
by Application • Raw Material • In-Process
by End-User • Pharmaceutical • Biotechnology • CMO

Global Bioburden Testing Market, by Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Bioburden Testing Market Key Players:

• Charles River Laboratories International Inc. • Sigma-Aldrich Corporation • SGS S.A. • Wuxi Pharmatech (CAYMAN) Inc. • Merck & Co. Inc. • Becton, Dickinson, and Company • North American Science Associates Inc. • Nelson Laboratories Inc. • Pacific Biolabs • ATS Labs Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Bioburden Testing Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Bioburden Testing Market? Ans: The Global Bioburden Testing Market is growing at a CAGR of 13.4% during forecasting period 2022-2027. 3. What is scope of the Global Bioburden Testing market report? Ans: Global Bioburden Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Bioburden Testing market? Ans: The important key players in the Global Bioburden Testing Market are – Charles River Laboratories International Inc., Sigma-Aldrich Corporation, SGS S.A., Wuxi Pharmatech (CAYMAN) Inc., Merck & Co. Inc., Becton, Dickinson, and Company, North American Science Associates Inc., Nelson Laboratories Inc., Pacific Biolabs, and ATS Labs Inc. 5. What is the study period of this market? Ans: The Global Bioburden Testing Market is studied from 2021 to 2027.
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Bioburden Testing Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Bioburden Testing Market Analysis and Forecast 6.1. Global Bioburden Testing Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Bioburden Testing Market Analysis and Forecast, By Test 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Bioburden Testing Market Value Share Analysis, By Test 7.4. Global Bioburden Testing Market Size (US$ Bn) Forecast, By Test 7.5. Global Bioburden Testing Market Analysis, By Test 7.6. Global Bioburden Testing Market Attractiveness Analysis, By Test 8. Global Bioburden Testing Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Bioburden Testing Market Value Share Analysis, By Application 8.4. Global Bioburden Testing Market Size (US$ Bn) Forecast, By Application 8.5. Global Bioburden Testing Market Analysis, By Application 8.6. Global Bioburden Testing Market Attractiveness Analysis, By Application 9. Global Bioburden Testing Market Analysis and Forecast, By Product 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Bioburden Testing Market Value Share Analysis, By Product 9.4. Global Bioburden Testing Market Size (US$ Bn) Forecast, By Product 9.5. Global Bioburden Testing Market Analysis, By Product 9.6. Global Bioburden Testing Market Attractiveness Analysis, By Product 10. Global Bioburden Testing Market Analysis and Forecast, by End-user 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Bioburden Testing Market Value Share Analysis, by End-user 10.4. Global Bioburden Testing Market Size (US$ Bn) Forecast, by End-user 10.5. Global Bioburden Testing Market Analysis, by End-user 10.6. Global Bioburden Testing Market Attractiveness Analysis, by End-user 11. Global Bioburden Testing Market Analysis, by Region 11.1. Global Bioburden Testing Market Value Share Analysis, by Region 11.2. Global Bioburden Testing Market Size (US$ Bn) Forecast, by Region 11.3. Global Bioburden Testing Market Attractiveness Analysis, by Region 12. North America Bioburden Testing Market Analysis 12.1. Key Findings 12.2. North America Bioburden Testing Market Overview 12.3. North America Bioburden Testing Market Value Share Analysis, By Test 12.4. North America Bioburden Testing Market Forecast, By Test 12.4.1. Aerobic 12.4.2. Anaerobic 12.4.3. Fungi 12.4.4. Spore 12.5. North America Bioburden Testing Market Value Share Analysis, By Application 12.6. North America Bioburden Testing Market Forecast, By Application 12.6.1. Raw Material 12.6.2. In-Process 12.7. North America Bioburden Testing Market Value Share Analysis, By Product 12.8. North America Bioburden Testing Market Forecast, By Product 12.8.1. Instruments 12.8.1.1. PCR 12.8.1.2. Microscopes 12.8.2. Consumables 12.8.3. Kits 12.8.4. Reagents 12.9. North America Bioburden Testing Market Value Share Analysis, by End-user 12.10. North America Bioburden Testing Market Forecast, by End-user 12.10.1. Pharmaceutical 12.10.2. Biotechnology 12.10.3. CMO 12.11. North America Bioburden Testing Market Value Share Analysis, by Country 12.12. North America Bioburden Testing Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Bioburden Testing Market Analysis, by Country 12.14. U.S. Bioburden Testing Market Forecast, By Test 12.14.1. Aerobic 12.14.2. Anaerobic 12.14.3. Fungi 12.14.4. Spore 12.15. U.S. Bioburden Testing Market Forecast, By Application 12.15.1. Raw Material 12.15.2. In-Process 12.16. U.S. Bioburden Testing Market Forecast, By Product 12.16.1. Instruments 12.16.1.1. PCR 12.16.1.2. Microscopes 12.16.2. Consumables 12.16.3. Kits 12.16.4. Reagents 12.17. U.S. Bioburden Testing Market Forecast, by End-user 12.17.1. Pharmaceutical 12.17.2. Biotechnology 12.17.3. CMO 12.18. Canada Bioburden Testing Market Forecast, By Test 12.18.1. Aerobic 12.18.2. Anaerobic 12.18.3. Fungi 12.18.4. Spore 12.19. Canada Bioburden Testing Market Forecast, By Application 12.19.1. Raw Material 12.19.2. In-Process 12.20. Canada Bioburden Testing Market Forecast, By Product 12.20.1. Instruments 12.20.1.1. PCR 12.20.1.2. Microscopes 12.20.2. Consumables 12.20.3. Kits 12.20.4. Reagents 12.21. Canada Bioburden Testing Market Forecast, by End-user 12.21.1. Pharmaceutical 12.21.2. Biotechnology 12.21.3. CMO 12.22. North America Bioburden Testing Market Attractiveness Analysis 12.22.1. By Test 12.22.2. By Application 12.22.3. By Product 12.22.4. By End-user 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Bioburden Testing Market Analysis 13.1. Key Findings 13.2. Europe Bioburden Testing Market Overview 13.3. Europe Bioburden Testing Market Value Share Analysis, By Test 13.4. Europe Bioburden Testing Market Forecast, By Test 13.4.1. Aerobic 13.4.2. Anaerobic 13.4.3. Fungi 13.4.4. Spore 13.5. Europe Bioburden Testing Market Value Share Analysis, By Application 13.6. Europe Bioburden Testing Market Forecast, By Application 13.6.1. Raw Material 13.6.2. In-Process 13.7. Europe Bioburden Testing Market Value Share Analysis, By Product 13.8. Europe Bioburden Testing Market Forecast, By Product 13.8.1. Instruments 13.8.1.1. PCR 13.8.1.2. Microscopes 13.8.2. Consumables 13.8.3. Kits 13.8.4. Reagents 13.9. Europe Bioburden Testing Market Value Share Analysis, by End-user 13.10. Europe Bioburden Testing Market Forecast, by End-user 13.10.1. Pharmaceutical 13.10.2. Biotechnology 13.10.3. CMO 13.11. Europe Bioburden Testing Market Value Share Analysis, by Country 13.12. Europe Bioburden Testing Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Bioburden Testing Market Analysis, by Country 13.14. Germany Bioburden Testing Market Forecast, By Test 13.14.1. Aerobic 13.14.2. Anaerobic 13.14.3. Fungi 13.14.4. Spore 13.15. Germany Bioburden Testing Market Forecast, By Application 13.15.1. Raw Material 13.15.2. In-Process 13.16. Germany Bioburden Testing Market Forecast, By Product 13.16.1. Instruments 13.16.1.1. PCR 13.16.1.2. Microscopes 13.16.2. Consumables 13.16.3. Kits 13.16.4. Reagents 13.17. Germany Bioburden Testing Market Forecast, by End-user 13.17.1. Pharmaceutical 13.17.2. Biotechnology 13.17.3. CMO 13.18. U.K. Bioburden Testing Market Forecast, By Test 13.18.1. Aerobic 13.18.2. Anaerobic 13.18.3. Fungi 13.18.4. Spore 13.19. U.K. Bioburden Testing Market Forecast, By Application 13.19.1. Raw Material 13.19.2. In-Process 13.20. U.K. Bioburden Testing Market Forecast, By Product 13.20.1. Instruments 13.20.1.1. PCR 13.20.1.2. Microscopes 13.20.2. Consumables 13.20.3. Kits 13.20.4. Reagents 13.21. U.K. Bioburden Testing Market Forecast, by End-user 13.21.1. Pharmaceutical 13.21.2. Biotechnology 13.21.3. CMO 13.22. France Bioburden Testing Market Forecast, By Test 13.22.1. Aerobic 13.22.2. Anaerobic 13.22.3. Fungi 13.22.4. Spore 13.23. France Bioburden Testing Market Forecast, By Application 13.23.1. Raw Material 13.23.2. In-Process 13.24. France Bioburden Testing Market Forecast, By Product 13.24.1. Instruments 13.24.1.1. PCR 13.24.1.2. Microscopes 13.24.2. Consumables 13.24.3. Kits 13.24.4. Reagents 13.25. France Bioburden Testing Market Forecast, by End-user 13.25.1. Pharmaceutical 13.25.2. Biotechnology 13.25.3. CMO 13.26. Italy Bioburden Testing Market Forecast, By Test 13.26.1. Aerobic 13.26.2. Anaerobic 13.26.3. Fungi 13.26.4. Spore 13.27. Italy Bioburden Testing Market Forecast, By Application 13.27.1. Raw Material 13.27.2. In-Process 13.28. Italy Bioburden Testing Market Forecast, By Product 13.28.1. Instruments 13.28.1.1. PCR 13.28.1.2. Microscopes 13.28.2. Consumables 13.28.3. Kits 13.28.4. Reagents 13.29. Italy Bioburden Testing Market Forecast, by End-user 13.29.1. Pharmaceutical 13.29.2. Biotechnology 13.29.3. CMO 13.30. Spain Bioburden Testing Market Forecast, By Test 13.30.1. Aerobic 13.30.2. Anaerobic 13.30.3. Fungi 13.30.4. Spore 13.31. Spain Bioburden Testing Market Forecast, By Application 13.31.1. Raw Material 13.31.2. In-Process 13.32. Spain Bioburden Testing Market Forecast, By Product 13.32.1. Instruments 13.32.1.1. PCR 13.32.1.2. Microscopes 13.32.2. Consumables 13.32.3. Kits 13.32.4. Reagents 13.33. Spain Bioburden Testing Market Forecast, by End-user 13.33.1. Pharmaceutical 13.33.2. Biotechnology 13.33.3. CMO 13.34. Rest of Europe Bioburden Testing Market Forecast, By Test 13.34.1. Aerobic 13.34.2. Anaerobic 13.34.3. Fungi 13.34.4. Spore 13.35. Rest of Europe Bioburden Testing Market Forecast, By Application 13.35.1. Raw Material 13.35.2. In-Process 13.36. Rest of Europe Bioburden Testing Market Forecast, By Product 13.36.1. Instruments 13.36.1.1. PCR 13.36.1.2. Microscopes 13.36.2. Consumables 13.36.3. Kits 13.36.4. Reagents 13.37. Rest Of Europe Bioburden Testing Market Forecast, by End-user 13.37.1. Pharmaceutical 13.37.2. Biotechnology 13.37.3. CMO 13.38. Europe Bioburden Testing Market Attractiveness Analysis 13.38.1. By Test 13.38.2. By Application 13.38.3. By Product 13.38.4. By End-user 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Bioburden Testing Market Analysis 14.1. Key Findings 14.2. Asia Pacific Bioburden Testing Market Overview 14.3. Asia Pacific Bioburden Testing Market Value Share Analysis, By Test 14.4. Asia Pacific Bioburden Testing Market Forecast, By Test 14.4.1. Aerobic 14.4.2. Anaerobic 14.4.3. Fungi 14.4.4. Spore 14.5. Asia Pacific Bioburden Testing Market Value Share Analysis, By Application 14.6. Asia Pacific Bioburden Testing Market Forecast, By Application 14.6.1. Raw Material 14.6.2. In-Process 14.7. Asia Pacific Bioburden Testing Market Value Share Analysis, By Product 14.8. Asia Pacific Bioburden Testing Market Forecast, By Product 14.8.1. Instruments 14.8.1.1. PCR 14.8.1.2. Microscopes 14.8.2. Consumables 14.8.3. Kits 14.8.4. Reagents 14.9. Asia Pacific Bioburden Testing Market Value Share Analysis, by End-user 14.10. Asia Pacific Bioburden Testing Market Forecast, by End-user 14.10.1. Pharmaceutical 14.10.2. Biotechnology 14.10.3. CMO 14.11. Asia Pacific Bioburden Testing Market Value Share Analysis, by Country 14.12. Asia Pacific Bioburden Testing Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Bioburden Testing Market Analysis, by Country 14.14. China Bioburden Testing Market Forecast, By Test 14.14.1. Aerobic 14.14.2. Anaerobic 14.14.3. Fungi 14.14.4. Spore 14.15. China Bioburden Testing Market Forecast, By Application 14.15.1. Raw Material 14.15.2. In-Process 14.16. China Bioburden Testing Market Forecast, By Product 14.16.1. Instruments 14.16.1.1. PCR 14.16.1.2. Microscopes 14.16.2. Consumables 14.16.3. Kits 14.16.4. Reagents 14.17. China Bioburden Testing Market Forecast, by End-user 14.17.1. Pharmaceutical 14.17.2. Biotechnology 14.17.3. CMO 14.18. India Bioburden Testing Market Forecast, By Test 14.18.1. Aerobic 14.18.2. Anaerobic 14.18.3. Fungi 14.18.4. Spore 14.19. India Bioburden Testing Market Forecast, By Application 14.19.1. Raw Material 14.19.2. In-Process 14.20. India Bioburden Testing Market Forecast, By Product 14.20.1. Instruments 14.20.1.1. PCR 14.20.1.2. Microscopes 14.20.2. Consumables 14.20.3. Kits 14.20.4. Reagents 14.21. India Bioburden Testing Market Forecast, by End-user 14.21.1. Pharmaceutical 14.21.2. Biotechnology 14.21.3. CMO 14.22. Japan Bioburden Testing Market Forecast, By Test 14.22.1. Aerobic 14.22.2. Anaerobic 14.22.3. Fungi 14.22.4. Spore 14.23. Japan Bioburden Testing Market Forecast, By Application 14.23.1. Raw Material 14.23.2. In-Process 14.24. Japan Bioburden Testing Market Forecast, By Product 14.24.1. Instruments 14.24.1.1. PCR 14.24.1.2. Microscopes 14.24.2. Consumables 14.24.3. Kits 14.24.4. Reagents 14.25. Japan Bioburden Testing Market Forecast, by End-user 14.25.1. Pharmaceutical 14.25.2. Biotechnology 14.25.3. CMO 14.26. ASEAN Bioburden Testing Market Forecast, By Test 14.26.1. Aerobic 14.26.2. Anaerobic 14.26.3. Fungi 14.26.4. Spore 14.27. ASEAN Bioburden Testing Market Forecast, By Application 14.27.1. Raw Material 14.27.2. In-Process 14.28. ASEAN Bioburden Testing Market Forecast, By Product 14.28.1. Instruments 14.28.1.1. PCR 14.28.1.2. Microscopes 14.28.2. Consumables 14.28.3. Kits 14.28.4. Reagents 14.29. ASEAN Bioburden Testing Market Forecast, by End-user 14.29.1. Pharmaceutical 14.29.2. Biotechnology 14.29.3. CMO 14.30. Rest of Asia Pacific Bioburden Testing Market Forecast, By Test 14.30.1. Aerobic 14.30.2. Anaerobic 14.30.3. Fungi 14.30.4. Spore 14.31. Rest of Asia Pacific Bioburden Testing Market Forecast, By Application 14.31.1. Raw Material 14.31.2. In-Process 14.32. Rest of Asia Pacific Bioburden Testing Market Forecast, By Product 14.32.1. Instruments 14.32.1.1. PCR 14.32.1.2. Microscopes 14.32.2. Consumables 14.32.3. Kits 14.32.4. Reagents 14.33. Rest of Asia Pacific Bioburden Testing Market Forecast, by End-user 14.33.1. Pharmaceutical 14.33.2. Biotechnology 14.33.3. CMO 14.34. Asia Pacific Bioburden Testing Market Attractiveness Analysis 14.34.1. By Test 14.34.2. By Application 14.34.3. By Product 14.34.4. By End-user 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Bioburden Testing Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Bioburden Testing Market Overview 15.3. Middle East & Africa Bioburden Testing Market Value Share Analysis, By Test 15.4. Middle East & Africa Bioburden Testing Market Forecast, By Test 15.4.1. Aerobic 15.4.2. Anaerobic 15.4.3. Fungi 15.4.4. Spore 15.5. Middle East & Africa Bioburden Testing Market Value Share Analysis, By Application 15.6. Middle East & Africa Bioburden Testing Market Forecast, By Application 15.6.1. Raw Material 15.6.2. In-Process 15.7. Middle East & Africa Bioburden Testing Market Value Share Analysis, By Product 15.8. Middle East & Africa Bioburden Testing Market Forecast, By Product 15.8.1. Instruments 15.8.1.1. PCR 15.8.1.2. Microscopes 15.8.2. Consumables 15.8.3. Kits 15.8.4. Reagents 15.9. Middle East & Africa Bioburden Testing Market Value Share Analysis, by End-user 15.10. Middle East & Africa Bioburden Testing Market Forecast, by End-user 15.10.1. Pharmaceutical 15.10.2. Biotechnology 15.10.3. CMO 15.11. Middle East & Africa Bioburden Testing Market Value Share Analysis, by Country 15.12. Middle East & Africa Bioburden Testing Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Bioburden Testing Market Analysis, by Country 15.14. GCC Bioburden Testing Market Forecast, By Test 15.14.1. Aerobic 15.14.2. Anaerobic 15.14.3. Fungi 15.14.4. Spore 15.15. GCC Bioburden Testing Market Forecast, By Application 15.15.1. Raw Material 15.15.2. In-Process 15.16. GCC Bioburden Testing Market Forecast, By Product 15.16.1. Instruments 15.16.1.1. PCR 15.16.1.2. Microscopes 15.16.2. Consumables 15.16.3. Kits 15.16.4. Reagents 15.17. GCC Bioburden Testing Market Forecast, by End-user 15.17.1. Pharmaceutical 15.17.2. Biotechnology 15.17.3. CMO 15.18. South Africa Bioburden Testing Market Forecast, By Test 15.18.1. Aerobic 15.18.2. Anaerobic 15.18.3. Fungi 15.18.4. Spore 15.19. South Africa Bioburden Testing Market Forecast, By Application 15.19.1. Raw Material 15.19.2. In-Process 15.20. South Africa Bioburden Testing Market Forecast, By Product 15.20.1. Instruments 15.20.1.1. PCR 15.20.1.2. Microscopes 15.20.2. Consumables 15.20.3. Kits 15.20.4. Reagents 15.21. South Africa Bioburden Testing Market Forecast, by End-user 15.21.1. Pharmaceutical 15.21.2. Biotechnology 15.21.3. CMO 15.22. Rest of Middle East & Africa Bioburden Testing Market Forecast, By Test 15.22.1. Aerobic 15.22.2. Anaerobic 15.22.3. Fungi 15.22.4. Spore 15.23. Rest of Middle East & Africa Bioburden Testing Market Forecast, By Application 15.23.1. Raw Material 15.23.2. In-Process 15.24. Rest of Middle East & Africa Bioburden Testing Market Forecast, By Product 15.24.1. Instruments 15.24.1.1. PCR 15.24.1.2. Microscopes 15.24.2. Consumables 15.24.3. Kits 15.24.4. Reagents 15.25. Rest of Middle East & Africa Bioburden Testing Market Forecast, by End-user 15.25.1. Pharmaceutical 15.25.2. Biotechnology 15.25.3. CMO 15.26. Middle East & Africa Bioburden Testing Market Attractiveness Analysis 15.26.1. By Test 15.26.2. By Application 15.26.3. By Product 15.26.4. By End-user 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Bioburden Testing Market Analysis 16.1. Key Findings 16.2. South America Bioburden Testing Market Overview 16.3. South America Bioburden Testing Market Value Share Analysis, By Test 16.4. South America Bioburden Testing Market Forecast, By Test 16.4.1. Aerobic 16.4.2. Anaerobic 16.4.3. Fungi 16.4.4. Spore 16.5. South America Bioburden Testing Market Value Share Analysis, By Application 16.6. South America Bioburden Testing Market Forecast, By Application 16.6.1. Raw Material 16.6.2. In-Process 16.7. South America Bioburden Testing Market Value Share Analysis, By Product 16.8. South America Bioburden Testing Market Forecast, By Product 16.8.1. Instruments 16.8.1.1. PCR 16.8.1.2. Microscopes 16.8.2. Consumables 16.8.3. Kits 16.8.4. Reagents 16.9. South America Bioburden Testing Market Value Share Analysis, by End-user 16.10. South America Bioburden Testing Market Forecast, by End-user 16.10.1. Pharmaceutical 16.10.2. Biotechnology 16.10.3. CMO 16.11. South America Bioburden Testing Market Value Share Analysis, by Country 16.12. South America Bioburden Testing Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Bioburden Testing Market Analysis, by Country 16.14. Brazil Bioburden Testing Market Forecast, By Test 16.14.1. Aerobic 16.14.2. Anaerobic 16.14.3. Fungi 16.14.4. Spore 16.15. Brazil Bioburden Testing Market Forecast, By Application 16.15.1. Raw Material 16.15.2. In-Process 16.16. Brazil Bioburden Testing Market Forecast, By Product 16.16.1. Instruments 16.16.1.1. PCR 16.16.1.2. Microscopes 16.16.2. Consumables 16.16.3. Kits 16.16.4. Reagents 16.17. Brazil Bioburden Testing Market Forecast, by End-user 16.17.1. Pharmaceutical 16.17.2. Biotechnology 16.17.3. CMO 16.18. Mexico Bioburden Testing Market Forecast, By Test 16.18.1. Aerobic 16.18.2. Anaerobic 16.18.3. Fungi 16.18.4. Spore 16.19. Mexico Bioburden Testing Market Forecast, By Application 16.19.1. Raw Material 16.19.2. In-Process 16.20. Mexico Bioburden Testing Market Forecast, By Product 16.20.1. Instruments 16.20.1.1. PCR 16.20.1.2. Microscopes 16.20.2. Consumables 16.20.3. Kits 16.20.4. Reagents 16.21. Mexico Bioburden Testing Market Forecast, by End-user 16.21.1. Pharmaceutical 16.21.2. Biotechnology 16.21.3. CMO 16.22. Rest of South America Bioburden Testing Market Forecast, By Test 16.22.1. Aerobic 16.22.2. Anaerobic 16.22.3. Fungi 16.22.4. Spore 16.23. Rest of South America Bioburden Testing Market Forecast, By Application 16.23.1. Raw Material 16.23.2. In-Process 16.24. Rest of South America Bioburden Testing Market Forecast, By Product 16.24.1. Instruments 16.24.1.1. PCR 16.24.1.2. Microscopes 16.24.2. Consumables 16.24.3. Kits 16.24.4. Reagents 16.25. Rest of South America Bioburden Testing Market Forecast, by End-user 16.25.1. Pharmaceutical 16.25.2. Biotechnology 16.25.3. CMO 16.26. South America Bioburden Testing Market Attractiveness Analysis 16.26.1. By Test 16.26.2. By Application 16.26.3. By Product 16.26.4. By End-user 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Charles River Laboratories International Inc. 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Company Footprint 17.3.2. Sigma-Aldrich Corporation 17.3.3. SGS S.A. 17.3.4. Wuxi Pharmatech (CAYMAN) Inc. 17.3.5. Merck & Co. Inc. 17.3.6. Becton, Dickinson, and Company 17.3.7. North American Science Associates Inc. 17.3.8. Nelson Laboratories Inc. 17.3.9. Pacific Biolabs 17.3.10. ATS Labs Inc. 18. Primary Key Insights

About This Report

Report ID 35280
Category Biotechnology
Published Date oct 2019
Updated Date Mar 2022
Contact Us